IRADIMED CORPORATION

NasdaqGM:IRMD Stock Report

Market Cap: US$912.8m

IRADIMED Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGM:IRMD Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
06 Aug 25SellUS$76,148Monty AllenIndividual1,102US$69.10
02 Dec 24SellUS$135,449John GlennIndividual2,500US$54.18
06 Nov 24SellUS$150,616Anthony VuotoIndividual2,690US$55.99

Insider Trading Volume

Insider Buying: IRMD insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of IRMD?
Owner TypeNumber of SharesOwnership Percentage
State or Government00%
Hedge Funds872,0036.86%
General Public946,9667.44%
Individual Insiders4,661,45436.6%
Institutions6,239,57949.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 79.67% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
36%
Roger Susi
4,572,950US$328.2m-0.33%no data
7.57%
BlackRock, Inc.
962,336US$69.1m1.69%no data
6.86%
Nine Ten Capital Management, LLC
872,003US$62.6m0%16.27%
4.41%
The Vanguard Group, Inc.
561,032US$40.3m1.19%no data
3.87%
Renaissance Technologies LLC
491,812US$35.3m-1.97%0.04%
3.6%
Copeland Capital Management, LLC
457,919US$32.9m-6.65%0.65%
2.05%
Geode Capital Management, LLC
261,386US$18.8m6.52%no data
1.69%
Dimensional Fund Advisors LP
215,426US$15.5m-2.16%no data
1.69%
Ranger Investment Management, L.P.
214,840US$15.4m7.36%1.05%
1.39%
State Street Global Advisors, Inc.
177,389US$12.7m0.97%no data
1.21%
Acadian Asset Management LLC
154,239US$11.1m-1.33%0.02%
1.17%
Russell Investment Management, LLC
148,565US$10.7m-3.09%0.01%
1.13%
Northern Trust Global Investments
143,228US$10.3m-10.1%no data
0.88%
Millennium Management LLC
111,628US$8.0m59.1%0.01%
0.82%
BNY Asset Management
103,787US$7.4m2.09%no data
0.8%
Goldman Sachs Asset Management, L.P.
101,475US$7.3m-5.31%no data
0.63%
Uniplan Investment Counsel, Inc.
80,347US$5.8m64.9%0.58%
0.56%
Roubaix Capital, LLC
71,497US$5.1m48.6%2.11%
0.53%
Charles Schwab Investment Management, Inc.
67,286US$4.8m3.4%no data
0.53%
Envestnet Asset Management, Inc.
67,103US$4.8m-4.78%no data
0.5%
Rice Hall James & Associates, LLC
64,022US$4.6m-7.87%0.22%
0.47%
HighTower Advisors, LLC
60,361US$4.3m0%0.01%
0.47%
Bridge City Capital, LLC
60,178US$4.3m-1.6%1.13%
0.45%
Isthmus Partners, LLC
57,344US$4.1m-0.79%0.46%
0.44%
Morgan Stanley
55,461US$4.0m7.58%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/07 23:36
End of Day Share Price 2025/10/07 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

IRADIMED CORPORATION is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Lawrence SolowCJS Securities, Inc.
Frank TakkinenLake Street Capital Markets, LLC
Jason WittesRoth Capital Partners